Last reviewed · How we verify
NCT04493554
The Effects of Vasopressin on Attention Control
NA trial testing Vasopressin in Healthy in 89 participants. Completed in 1 January 2021.
30 November 2020
Quick facts
| Lead sponsor | University of Electronic Science and Technology of China |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | basic science |
| Enrollment | 89 |
| Start date | 28 July 2020 |
| Primary completion | 30 November 2020 |
| Estimated completion | 1 January 2021 |
| Sites | 1 location across China |
Drugs / interventions tested
- Vasopressin — full drug profile →
- Placebo
Conditions studied
- Healthy — all drugs for Healthy →
Sponsor
University of Electronic Science and Technology of China
Who can join
Adults 18 to 30, male only, with Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main aim of the present study is to investigate whether intranasal vasopressin (20IU) could influence attention control in a social-emotional saccade/antisaccade eye-tracking paradigm.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Nose-to-Brain Delivery of Therapeutic Peptides as Nasal Aerosols.
Alabsi W, Eedara BB, Encinas-Basurto D, Polt R, et al · · 2022 · cited 44× · PMID 36145618 · DOI 10.3390/pharmaceutics14091870
Verify or expand the search:
- PubMed search for NCT04493554
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Vasopressin
Trials testing the same drug.
- NCT06426407 — Vasopressin Hemodynamic Response as a Septic Shock Subphenotype Indicator · terminated
- NCT06547892 — Use of Vasopressin in Patients at High Risk of Acute Kidney Injury Admitted to the ICU · Phase 2 · recruiting
- NCT06419075 — Tranexamic Acid in Vaginal Reconstructive Surgery · Phase 4 · withdrawn
- NCT06290596 — Vasopressin Versus Tranexamic Acid for Control of Blood Loss Related to Abdominal Hysterectomy · Phase 4 · unknown
- NCT06329037 — The Effects of Oral Vasopressin on Attention Control: An Eye-tracking Study · NA · recruiting
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other University of Electronic Science and Technology of China trials
Trials by the same sponsor.
- NCT07416370 — Neurofeedback Training of Anterior Insula Activity Based on Unidimensional vs. Multidimensional Interoceptive Regulation · NA · enrolling by invitation
- NCT07389486 — Continuous vs. Intermittent Rt-fMRI Neurofeedback Training of the Anterior Insula · NA · recruiting
- NCT07425938 — Oxytocin's Effects on Emotional Processing and Its Acting Routes · NA · recruiting
- NCT07364084 — Real-time Neurofeedback Training of the Medial Prefrontal Cortex Based on Imagined Social Support · NA · recruiting
- NCT07367672 — The Power of Belief: Expectation-driven and Placebo Modulation of Empathic Pain · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04493554 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Electronic Science and Technology of China
- Last refreshed: 7 January 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04493554.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing